Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Label, Prospective Study of the Sylfirm X Device for the Treatment of Melasma

NCT06415435 is registered in ClinicalTrials.gov with Benev Company, Inc. as lead sponsor.

NCT NCT06415435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06415435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Label, Prospective Study of the Sylfirm X Device for the Treatment of Melasma
Lead sponsor
Benev Company, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2023
Completion date
October 1, 2024
Enrollment
90 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

melasma